文献速递气道管理术前评估与围术期医学

硫酸镁预处理后罗库溴铵标准插管剂量与琥珀胆碱用于快速序贯诱导的比较:一项随机临床试验

Rapid Sequence Induction With a Standard Intubation Dose of Rocuronium After Magnesium Pretreatment Compared With Succinylcholine: A Randomized Clinical Trial.
PubMed 文献 · Anesth Analg · 2021-01-01

该随机临床试验纳入280例成人,比较硫酸镁预处理后罗库溴铵0.6 mg·kg-1与琥珀胆碱1 mg·kg-1用于快速序贯诱导的插管条件。硫酸镁-罗库溴铵组不良事件发生率更低(11% vs 28%)。

要点

  • 硫酸镁预处理后罗库溴铵标准剂量未优于琥珀胆碱的插管条件。
  • 硫酸镁-罗库溴铵组不良事件更少,主要为术后肌痛和组胺释放相关表现。
  • 女性优异插管条件率高于男性(54% vs 37%,校正RR 1.42)。

核心结论

  • 硫酸镁预处理后罗库溴铵标准插管剂量未提供优于琥珀胆碱的插管条件,但不良事件更少。

研究设计与样本

  • 随机临床试验,280例成人随机分组,259例可分析插管条件(硫酸镁-罗库溴铵组133例,生理盐水-琥珀胆碱组126例)。

主要发现

  • 生理盐水-琥珀胆碱组不良事件主要为术后肌痛26例(19%)和组胺释放征象13例(9%)。
  • 硫酸镁-罗库溴铵组少数患者出现注射痛、恶心呕吐或硫酸镁输注期间皮疹5例(4%)。

关键数值与推荐

  • 硫酸镁剂量60 mg·kg-1,15分钟静脉输注,随后丙泊酚2 mg·kg-1、舒芬太尼0.2 μg·kg-1、罗库溴铵0.6 mg·kg-1。
  • 对照组生理盐水15分钟静脉输注,随后相同诱导方案但琥珀胆碱1 mg·kg-1。
  • 主要终点为神经肌肉阻滞剂给药后60秒优异插管条件率。

临床怎么用

  • 硫酸镁预处理后罗库溴铵标准剂量可作为琥珀胆碱的替代方案,但插管条件无优势。
  • 该方案不良事件更少,尤其减少术后肌痛和组胺释放相关表现。

局限性

  • 原文摘要未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Succinylcholine remains the muscle relaxant of choice for rapid sequence induction (RSI) but has many adverse effects. High-dose rocuronium bromide may be an alternative to succinylcholine for RSI but recovery times are nearly doubled compared with a standard intubating dose of rocuronium. Magnesium sulfate significantly shortens the onset time of a standard intubating dose of rocuronium. We set out to investigate whether intravenous (IV) pretreatment with MgSO4 followed by a standard intubating dose of rocuronium achieved superior intubation conditions compared with succinylcholine. METHODS: Adults were randomized to receive a 15-minute IV infusion of MgSO4 (60 mg·kg-1) immediately before RSI with propofol 2 mg·kg-1, sufentanil 0.2 μg·kg-1 and rocuronium 0.6 mg·kg-1, or a matching 15-minute IV infusion of saline immediately before an identical RSI, but with succinylcholine 1 mg·kg-1. Primary end point was the rate of excellent intubating conditions 60 seconds after administration of the neuromuscular blocking agent and compared between groups using multivariable log-binomial regression model. Secondary end points were blood pressure and heart rate before induction, before and after intubation, and adverse events up to 24 hours postoperatively. RESULTS: Among 280 randomized patients, intubating conditions could be analyzed in 259 (133 MgSO4-rocuronium and 126 saline-succinylcholine). The rate of excellent intubating conditions was 46% with MgSO4-rocuronium and 45% with saline-succinylcholine. The analysis adjusted for gender and center showed no superiority of MgSO4-rocuronium compared with saline-succinylcholine (relative risk [RR] 1.06, 95% confidence interval [CI], 0.81-1.39, P = .659). The rate of excellent intubating conditions was higher in women (54% [70 of 130]) compared with men (37% [48 of 129]; adjusted RR 1.42, 95% CI, 1.07-1.91, P = .017). No significant difference between groups was observed for systolic and diastolic blood pressures. Mean heart rate was significantly higher in the MgSO4-rocuronium group. The percentage of patients with at least 1 adverse event was lower with MgSO4-rocuronium (11%) compared with saline-succinylcholine (28%) (RR 0.38, 95% CI, 0.22-0.66, P < .001). With saline-succinylcholine, adverse events consisted mainly of postoperative muscle pain (n = 26 [19%]) and signs of histamine release (n = 13 [9%]). With MgSO4-rocuronium, few patients had pain on injection, nausea and vomiting, or skin rash during the MgSO4-infusion (n = 5 [4%]). CONCLUSIONS: IV pretreatment with MgSO4 followed by a standard intubating dose of rocuronium did not provide superior intubation conditions to succinylcholine but had fewer adverse effects.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Czarnetzki C, Albrecht E, Masouyé P, et al. Rapid Sequence Induction With a Standard Intubation Dose of Rocuronium After Magnesium Pretreatment Compared With Succinylcholine: A Randomized Clinical Trial. Anesth Analg. 2021. PMID: 33337797. doi:10.1213/ANE.0000000000005324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。